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ABSTRACT  Analysis of the effects of deoxycholate and benzalkonium chloride 
on granule relaxing activity, myofibril and glycerinated fiber responses to ATP, 
and  the sensitivity of these actomyosin-containing systems to relaxing  factors 
have established that it is possible to differentially inactivate intrinsic  granule 
relaxing  factor.  It is therefore possible to use these agents to treat myofibrils 
and glycerinated muscle fibers so that they may be used for the assay of muscle- 
relaxing factor preparations. The destruction of intrinsic relaxing factor can be 
produced by treating  actomyosin with  1 mM deoxycholate or 0.005  per cent 
benzalkonium chloride for 5 minutes at room temperature. 
INTRODUCTION 
Engelhardt  (1) first noted that ff contraction is the result of a reaction between 
ATP  1 and  actomyosin it is necessary to assume  that  some mechanism  exists 
whereby  this  reaction  is  prevented  from  taking  place  in  resting  muscle. 
Evidence that such a  mechanism actually exists has been presented by Bozler 
(2),  who  deduced  that  there  was  some substance  in  muscle  which  was  in- 
hibiting  the contraction  of "fresh" glycerinated muscle fibers and  by Marsh 
(3), who established that muscle homogenates inhibit ATP-induced syneresis. 
The  inhibitory  action  was  originally  presumed  to  be  produced  by  some 
substance in the homogenate termed "relaxing factor" and was subsequently 
shown  by  Bendall  (4)  to  produce  inhibition  (relaxation)  of ATP-induced 
tension generation  and  ATPase  activity of glycerol-extracted fiber bundles. 
Identification  of the  active  constituent  in  the  homogenate  indicated  that 
the activity was associated with a particulate  (granule)  fraction of the homog- 
enate  (5-7),  most  likely  the microsomal  fraction  (7-9).  In  order  to  explain 
how such granules,  with a  diameter  of approximately  1000 A  (9,  10),  could 
produce relaxation in a  glycerinated fiber or myofibril with intermyofilament 
1  Abbreviations: ATP, adenosinetriphosphate; ATPase, adenosinetriphosphatase; EDTA, ethylene- 
diaminetetraacetate; TCA, trichloroacetic acid; DOC, deoxycholate. 
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spacings of approximately  140  A  (11)  it is,  however,  necessary to postulate 
(8,  12) that they produce relaxation either by the removal of some component 
essential  for  actomyosin activity  or  by  synthesizing  and/or  releasing  some 
soluble, low molecular weight substance.  Evidence in favor of each of these 
mechanisms has  appeared.  It has  been  argued  that relaxation  is  solely the 
consequence of the uptake of calcium by the granules (13-15). This hypothesis 
assumes that  actomyosin contractility is  dependent upon the presence  of a 
small amount of calcium.  Evidence for such calcium dependence has  been 
presented  by A.  Weber  and  Winicur  (16),  A.  Weber  and  Herz  (17),  and 
Ebashi  (13).  According to the other postulate, based on the experiments of 
Briggs and Fuchs (18), Parker and Gergely (19), and Nagai (20), the inhibi- 
tion of actomyosin contractility requires the presence of a  soluble substance 
produced through  an  interaction between  granules  and  ATP.  In  terms  of 
this formulation the granule is considered to be an agent for the formation 
and/or release of the true soluble relaxing factor.  If this is  the case,  physi- 
ologically it should be possible to find the soluble inhibitor in muscle per  se. 
Fuchs and Briggs  (21)  thus reexamined the soluble supernatant fraction of 
muscle homogenates and found what appears to be the hypothetical soluble 
inhibitor.  Unfortunately,  most of the  investigations cited  in  favor  of both 
hypotheses are  somewhat ambiguous because  of possible  contamination of 
the actomyosin preparations  by remnants of endoplasmic reticulum  (gran- 
ules). According to Hasselbach (22) such remnants of sarcoplasmic reticulum 
can  be  seen in  electron micrographs of glycerinated fibers,  myofibrils,  and 
natural actomyosin although reconstituted actomyosin appears  to be free of 
such contamination. Whether these remnants of sarcoplasmic reticulum are 
functional relaxing systems was not determined. Ulbrecht (23), has however, 
shown that these vesicles catalyze an ATP-ADP  8~ exchange and hence it may 
be that they also possess some relaxing activity. 
The  experiments which form  the  following communications were under- 
taken  to  determine  the  nature  of the  material  in  the  soluble  supernatant 
which inhibits actomyosin contractility. Attention was first directed toward 
the development of unambiguous assays systems; i.e.,  actomyosin preparations 
free  of functional  vesicular  material.  Experiments  were  then  designed  to 
establish a  number of physicochemical properties of the supernatant relaxing 
system  in  order  to  decide  whether  or  not  the  properties  of  that  system 
could be accommodated by a  mere lack of calcium therein or whether the 
properties of the system are such that an inhibitor substance must be postu- 
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METHODS  AND  MATERIALS 
A.  Solutions 
Extraction solution was of the following composition: 30 mM potassium chloride,  10 mM 
potassium  phosphate,  I0  mM  histidine  hydrochloride,  5  mM  magnesium  chloride, 
5 rn~ potassium oxalate, pH 6.7.  Contraction solution was exactly equivalent to extrac- 
tion solution except that sodium adenosinetriphosphate, pH 6.7, was included to give 
a  concentration of 5 mM. 
B.  Preparation  of Relaxing Systems 
All  preparations were  derived  from the  skeletal  muscle  of 4  to  5  kg white  rabbits 
maintained  on standard rabbit chow. The animals were killed by intravenous injec- 
tion of sodium pentobarbital.  The back and  leg muscles were excised as rapidly as 
possible and chilled in ice. All subsequent operations were earned out in a  cold room 
at 2-4°C. One volume of chilled minced muscle was homogenized with 3 volumes of 
extraction solution for 40 seconds in a  Waring blendor. The homogenate was centri- 
fuged for 25 minutes at 11,000 g  to remove myofibrils, mitochondria, and connective 
tissue fragments.  The supernatant  so obtained  is  referred  to  as crude Marsh  extract. 
Crude  Marsh  extract was  passed  through  several layers of cheesecloth  and  centri- 
fuged for 2 hours at 78,000 g. The sediment containing vesicular material referred to 
as granules was washed  once with  extraction solution  and  with  the  aid  of a  Potter- 
Elvehjem homogenizer, was resuspended in a  volume of extraction solution equal to 
~0  the volume of crude extract. Thus,  1 ml of granular fraction contained material 
derived from 2.5 gm of muscle. The 78,000 g supernatant containing the soluble relax- 
ing activity is referred to simply as the supernatantfraction. All preparations were stored 
in polyethylene bottles in the cold room and were generally not used longer than a 
week. 
C.  Assay Systems 
Single,  glycerol-extracted fibers were prepared from rabbit psoas muscle according 
to the method of Szent-Gy6rgyi (24). When it was desired to have fibers contaminated 
with active intrinsic relaxing factor, the glycerol extraction was carried out for only 
2  to 4  days (2),  otherwise the fibers were extracted for more than 90 days. Tension 
generation  was  induced  in  these  fibers with  contraction  solution  and  recorded  iso- 
metrically with the aid of a RCA 5734 transducer tube or with a Cahn electrobalanee 
adapted  for  the  purpose. 
Myofibrils were  prepared  by  a  modification  of the  method  of Perry  (25).  One 
volume of minced rabbit muscle was homogenized for 1 minute in a  Waring blendor 
with 3 volumes of 70 mM tris, pH 7.0, containing 5 mM EDTA. EDTA was included 
to minimize spontaneous  shortening  of the  myofibNls during isolation.  The homog- 
enate was centrifuged  at  1,500 g for 15 minutes at 0-2°C. The supernatant was dis- 
carded and the sediment resuspended  in  70 mM tris by means of a  Waring blendor. 
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6 or 7 cycles of centrifugation and resuspension. After the final washing the myofibril 
sediment was suspended in  70 mM tris  to give a  protein concentration  of approxi- 
mately 20 to 25 mg/ml. The myofibril suspension was stored in a polyethylene bottle 
at 2-4°C and was discarded after 7 to 10 days. 
MyofibriUar and  actomyosin ATPase were measured  in  a  constant  temperature 
bath at 25°C, using a magnetic stirring device to insure rapid mixing.  The enzyme 
suspension  was  pipetted  into  the  reaction  vessel  containing  contraction  solution. 
Aliquots of 2 ml were removed at  10 seconds and 5 minutes and mixed with 2 ml of 
ice cold  10 per cent TCA. Inorganic phosphate was measured according to the pro- 
cedure of King (26) and the difference between the  10 second and 5 minute values 
was taken to represent the phosphate liberated in 5 minutes. Since the relaxing factor 
preparations often possessed some ATPase activity, separate determinations of phos- 
phate  liberation were made in the absence of actomyosin and  suitable corrections 
were made. 
Protein was estimated by the method of Lowry et al.  (27). 
RESULTS 
A  number  of surface-active agents  have previously been used  to destroy the 
intrinsic  relaxing  activity contaminating  glycerinated  fibers  and  myofibrils. 
Ebashi  (28) employed deoxycholate and benzalkonium chloride while Weber 
and  Herz  (17)  used  saturated  thymol solution.  The use of these  agents was 
based on their reported ability to destroy relaxing activity of isolated granules. 
Almost  no  information  has  been  reported  on  the  effects of these  agents  on 
such  properties  of  the  actomyosin  system  as  contractility  or  sensitivity  to 
EDTA  or  other  relaxing  agents.  Without  this  information  the  use  of these 
agents  for  the  purpose  of differentially  inactivating  the  vesicular  material 
contaminating  actomyosin preparations  is  highly  empirical. 
To  preferentially  destroy  any  granular  relaxing  material  contaminating 
myofibrils or glycerinated muscle fibers it is necessary to find a concentration 
of an  agent which will inactivate  granules  without modifying the activity of 
actomyosin.  The  first  agent  to  be  studied  for  such  properties  was  deoxy- 
cholate.  The  influence  of  various  concentrations  of  deoxycholate  on  the 
ability of granules  to  inhibit  myofibrillar ATPase  was  initially  investigated. 
Deoxycholate  was  added  to  extraction  solution  in  concentrations  between 
0.5  and  10.0 mM.  Ten volumes of this  solution was then  added  to  1 volume 
of the concentrated  granule  preparation  and  allowed to stand  at room tem- 
perature  for  5  minutes.  The  mixture  was  then  immediately  chilled  in  ice 
water  and  subjected  to  centrifugation  to  separate  the  granules  from  the 
deoxycholate.  The  granules  were  washed  twice  with  extraction  solution, 
suspended  in  extraction  solution,  and  tested  for  their  myofibrillar  ATPase- 
inhibiting  activity.  The  control  granules  were  treated  in  a  comparable 
manner.  The  results  of these  experiments,  presented  in  Fig.  1,  show  that F.  N.  BRmoS A..XD F.  FUCHS  Assay  System/or Musde-Relaxing Factor  887 
0.5 rr~ deoxycholate was relatively ineffective in destroying granule relaxing 
activity while  1,  5,  and  10 n~  deoxycholate were highly effective. 
A  quantitative  assessment  of  the  ability  of  deoxycholate  to  destroy  the 
relaxing activity of granules was then undertaken.  The granule fraction was 
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Fxoum~ 1.  Influence  of deoxycholate  treatment on granule relaxing  activity.  ATPase 
activity was measured as described in the text. Myofibrillar protein concentration, 5 mg 
in a final volume of 10 ml. 
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Fiou~ 2.  Comparison  of  relaxing  activities  of  deoxycholate-treated  and  control 
granule preparations.  Granule relaxing  activity assayed on glycerinated  fibers as de- 
scribed in text. 
exposed  to  1 mM deoxycholate for 5  minutes at room temperature and  then 
washed  free  of  deoxycholate.  The  influences  of  various  concentrations  of 
treated  granules  and  control  granules  on  the  tension  generation  of glyceri- 
nated fibers were then compared  (Fig.  2).  Clearly, 4  mg of granules treated 
with deoxycholate were less effective than 0.04  mg of non-treated  granules; 888  THE  JOURNAL  OP  GENERAL  PHYSIOLOGY  • VOLUME  4  6  • x963 
actually,  there was no evidence of any relaxing activity even at  the highest 
granule  concentration. 
To  determine  whether  deoxycholate  has  an  effect  on  actomyosin  the 
ATPase activity of deoxycholate-treated myofibrils was measured. Exposure 
to  deoxycholate was  for  a  period  of 5  minutes  at  room  temperature.  As 
indicated in Fig.  3,  if ATP were not present,  concentrations of deoxycholate 
up to 5 n~  were without influence on myoflbrillar ATPase. Ten mM deoxy- 
cholate was definitely  deleterious to myofibrillar  ATPase. If ATP were present, 
then the myofibrils were much more sensitive to  the inhibiting influence of 
deoxycholate. 
To determine the influence of deoxycholate on the sensitivity of actomyosin 
preparations  to  the  inhibitory  effects  of granules,  myofibrils  were  treated 
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Fmum~. 3.  Influence  of deoxycholate  on  myofibrillar  ATPase.  MyofibriUar ATPase 
measured as described in text. Myofibril protein, 5 mg in final volume of 10 ml. 
with either  1 or 5 mM deoxycholate for 5 minutes at room temperature, then 
washed three times with 70 mM tris. The capacity of various granule concen- 
trations to inhibit the ATPase activity of these deoxycholate-treated myofibrils 
relative  to  a  control myofibril preparation  is  shown  in  Fig.  4.  Clearly  the 
myofibrils treated with 5  mM deoxycholate have become almost completely 
resistant to the inhibitory effects of granules, while the myofibrils treated with 
1 mM deoxycholate showed nearly normal sensitivity to the inhibitory effects 
of granules.  At  100  per  cent  activity  the  non-treated  myofibrillar ATPase 
liberated 0.26 umole phosphate per minute per milligram myofibrillar protein, 
the myofibrils treated  with  1 mM  DOC,  0.23  umole phosphate  per  minute 
per  milligram  protein,  and  the  myofibrils  treated  with  5  mM  DOC,  0.24 
~mole phosphate per minute per milligram protein.  The sensitivity of glycer- 
inated fibers to EDTA after treatment with 1 or 5 mM deoxycholate was also 
investigated.  In a  manner similar to the observations just noted,  the muscle F.  N.  BP..IGOS AND 17.  Fucm  Assay  System  for Muscle-Relaxing Factor  889 
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Fzoums 4.  Influence  of deoxycholate  treatment  of myofibrils on  their  sensitivity  to 
granule relaxing activity. Myofibrillar ATPase measured as described in text. Myofibril 
protein, 5 mg in final volume of I0 ml. 
fibers  treated  with  5  rnM deoxycholate showed  only a  minimal response  to 2 
mu  EDTA  while  the fibers pretreated  with  1 mM deoxycholate responded  in 
a  normal manner. 
TABLE  I 
SURVEY  OF  THE  EFFECTS  OF  BENZALKONIUM  CHLORIDE 
ON  CONTRACTION  OF  GLYCERINATED  FIBERS,  GRANULE 
RELAXING  FACTOR,  AND  THEIR  INTERACTION 
Parameter investigated 
(a)  (b)  (d  (g) 
Capacity of 
granules to  Activity 
Benzalkonium chloride*  Temion  Response to  inhibit  tension  of intrinsic 
(w/v)  generation  granules•  generation~  factor 
pet" c~at 
5  X  10  -4  .... 
1  X  10  -3  -  -  +  ± 
5  X  10-  3  -  -  +  + 
1  X  lO  -~  -  ±  +  + 
+,indicates  destruction of normal activity;  --, indicates no effect on normal 
activity; ±,  indicates  less than  normal  activity. 
(a)  Untreated  fibers.  (b)  Benzalkonium-treated fibers tested with untreated 
granules.  (c)  Untreated  fibers  tested with  benzalkonium-treated  granules. 
(d) Fibers extracted 2 to 4  days, see Methods. 
* Exposure  to  benzalkonium  chloride  was  for  5  minutes  at  room  temper- 
ature. 
:~ The  response of glycerinated fibers to granules and the influence of benz- 
alkonium  chloride  on  granules  were  examined  with  fibers  extracted  for 
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Similar,  but not so exhaustive, exploration of the effects of benzalkonium 
chloride  on  glycerinated fibers,  granules,  and  the  interaction  between  the 
fibers and granules was undertaken. The results are summarized in Table I. 
As with deoxycholate, it appears that benzalkonium chloride can be used to 
preferentially destroy intrinsic relaxing factor. The data indicate  that  there 
is, as with deoxycholate, only a  narrow range of concentrations where benz- 
alkonium chloride can destroy the intrinsic  relaxing factor without altering 
the sensitivity of the fiber to the granule relaxing factor. 
DISCUSSION 
On  the basis  of the above evidence, it appears  that  the actomysin systems, 
glycerinated muscle fibers or myofibrils, treated with  l  mM deoxycholate or 
0.005  per  cent benzalkonium chloride at  room temperature for  5  minutes, 
are  free  of any  functional  granule  relaxing  factor.  This  means  that  such 
preparations,  if properly pretreated,  may be  used  for  the  assay of relaxing 
factors.  The  ease with which these preparations  are obtained  compared  to 
the  very  tedious  preparation  of purified  F-actin  and  myosin  makes  them 
very desirable for such assays. 
The data indicate that there is not a  large difference between the concen- 
tration  of the  surface agent which completely destroys the relaxing  system 
and the concentration of the agent which begins to alter the sensitivity of the 
actomyosin  system  to  the  relaxing  agent.  The  uncritical  use  of  surface- 
acdve agents for  the preferential destruction of the vesicular system would 
seem to  be  unjustified.  For  example,  Ebashi  (28)  suggests  that  exposure of 
glycerinated bundles of muscle fibers to 0.5 mM deoxycholate at room tem- 
perature for 3  minutes is sufficient to inactivate the granule relaxing factor. 
The  studies  presented here do not support  those findings.  Ebashi  (28)  also 
recommends  0.15  per  cent  benzalkonium  chloride;  though  the  current 
investigation suggests that this is sufficient to destroy the vesicular system, it 
was  found  that  such  a  concentration  does  decrease  the  sensitivity  of  the 
actomyosin system to relaxing agents. 
It is also clear that sensitivity to relaxing agents is lost at lower concentra- 
tions  of  the  surface-active  agents  than  is  the  capacity  of the  actomyosin 
systems to undergo syneresis or develop tension or catalyze the hydrolysis of 
ATP.  The  preferential  loss  of sensitivity  to  relaxing  agents  has  also  been 
noted by other investigators (I 6) and suggests that a high degree of structural 
specificity is  involved  in  the  interaction  between  actomyosin  and  relaxing 
agents. 
This work was done during the tenure of an Established Investlgatorship  of the American Heart 
Association by F. N. Briggs and a Whitehall Foundation Fellowship by F. Fuchs. The work was 
supported by research  grant No. H-6782 from the National Institutes of Health. 
Received for publication,  October 3, 1962. F. N.  BRIoCs AND F.  FUCHS  Assay  System  for Muscle-Relaxing Factor  891 
REFERENCES 
1.  ENOELHARDT, V. A., Advances Enzymol., 1946, 6, 147. 
2.  BOZLER,  E., d. Gen. Physiol., 1954, 38, 53. 
3.  MARSH, B. B., Biochim. et Biophysica Acta, 1952, 9, 247. 
4.  BENDALL,  J. R., J. Physiol., 1953, 121, 232. 
5.  KUMAGAI,  H., EBASHI, S., and TAKEDA, F., Nature, 1955, 176, 166. 
6.  EBASHI,  S., Arch. Biochem. and Biophysics, 1958, 76, 410. 
7.  PORTZEHL,  H., Biochim. et Biophysica Acta, 1957, 26,373. 
8.  LORAND, L.,  MOLNAR, J.,  and Moos,  C., in Conference on the Chemistry of 
Muscular Contraction, Tokyo, Igaku Shoin Ltd., 1957. 
9.  MUSCATELLO, U., ANDERSSoN-CEDERfiREN, E.,  and Azzos~,  G.  F.,  Biochim. et 
Biophysica Acta, 1961, 51, 426. 
10.  HUXLEY, H. E., in The Cell,  (J. Brachet and A. E. Mirsky, editors), New York, 
Academic Press Inc., 1960, 4, 436. 
11.  HuxLEY, H. E. and HANSON, J., in Muscle, (G.  H. Bourne, editor), New York, 
Academic Press  Inc.,  1960, 1,  183. 
12.  WEBER, H., Ann. New York Acad. Sc., 1959, 81,409. 
13.  EBASHI, S., J. Biochem., 1961, 50, 236. 
14.  PARKER, C. J., and G~.ROELY,  J., J. Biol. Chem., 1961, 236, 411. 
15.  HASSELEACH,  W., and MAKINOSE, M., Biochem. Z.,  1961, 333, 463. 
16.  WEBER, A., and W~ICUR, S., J. Biol. Chem., 1961, 236, 3198. 
17.  WEBER, A., and HERZ, R., Biochem. and Biophysic. Research Communications, 1962, 
6, 364. 
18.  BRICGS,  F. N., and FUCHS, F., Biochim. et Biophysica Acta, 1960, 42, 519. 
19.  PARKER,  C. J., and GERQELY,  J., J. Biol. Chem., 1960, 235, 3449. 
20.  NAOAI, T., UcnmA, D.,  and YASUDA, M., Biochim. et Biophysica Acta, 1962, 56, 
205. 
21.  Fucks, F., and BRIOGS, F. N., Biochim. et Biophysica Acta, 1961, 51, 423. 
22.  HASSELBACH,  W., personal communication, cited by A. Weber in reference 16. 
23.  ULER~CHT,  G., and ULBREC~rr,  M., Biochim. et Biophysica Acta, 1957, 25, 100. 
24.  SZENT-GYSRGYI,  A., Chemistry of Muscular Contraction, New York, Academic 
Press Inc., 1951. 
25.  PERRY,  S. V., Biochem. J.,  1952, 51, 495. 
26.  KING, E. J., Biochem. J.,  1932, 26, 294. 
27.  LOWRY, O. H., ROS~.BROUOH, N. J., FARR, A. L., and RANDALL,  R. J., J. Biol. 
Chem., 1951, 193, 265. 
28.  EBASHI,  S., EBAS~I, F., and FujxI, Y., J. Biochem., 1960, 47, 54. 